179 related articles for article (PubMed ID: 28420348)
21. Is Nebivolol Really Effective in Preventing Contrast Induced Nephropathy?
Altunoren O; Balli M; Eren N; Tasolar H; Arpaci A; Caglayan CE; Yavuz YC; Gungor O
Kidney Blood Press Res; 2015; 40(5):533-41. PubMed ID: 26496491
[TBL] [Abstract][Full Text] [Related]
22. Sodium bicarbonate versus isotonic saline for the prevention of contrast-induced nephropathy in patients with diabetes mellitus undergoing coronary angiography and/or intervention: a multicenter prospective randomized study.
Koc F; Ozdemir K; Altunkas F; Celik A; Dogdu O; Karayakali M; Gul EE; Erkorkmaz U; Kadi H; Akpek M; Kaya MG
J Investig Med; 2013 Jun; 61(5):872-7. PubMed ID: 23552179
[TBL] [Abstract][Full Text] [Related]
23. Impact of the definition utilized on the rate of contrast-induced nephropathy in percutaneous coronary intervention.
Jabara R; Gadesam RR; Pendyala LK; Knopf WD; Chronos N; Chen JP; Viel K; King SB; Manoukian SV
Am J Cardiol; 2009 Jun; 103(12):1657-62. PubMed ID: 19539072
[TBL] [Abstract][Full Text] [Related]
24. Circulating tumour necrosis factor receptors 1 and 2 predict contrast-induced nephropathy and progressive renal dysfunction: a prospective cohort study.
An JN; Yoo KD; Hwang JH; Kim HL; Kim SH; Yang SH; Kim JH; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
Nephrology (Carlton); 2015 Aug; 20(8):552-9. PubMed ID: 25783484
[TBL] [Abstract][Full Text] [Related]
25. Brain natriuretic peptide for prevention of contrast-induced nephropathy after percutaneous coronary intervention or coronary angiography.
Liu JM; Xie YN; Gao ZH; Zu XG; Li YJ; Hao YM; Chang L
Can J Cardiol; 2014 Dec; 30(12):1607-12. PubMed ID: 25418218
[TBL] [Abstract][Full Text] [Related]
26. GRACE risk score predicts contrast-induced nephropathy in patients with acute coronary syndrome and normal renal function.
Raposeiras-Roubín S; Aguiar-Souto P; Barreiro-Pardal C; López Otero D; Elices Teja J; Ocaranza Sanchez R; Cid Alvarez B; Trillo Nouche R; Maceiras MV; Abu-Assi E; García-Acuña JM; González-Juanatey JR
Angiology; 2013 Jan; 64(1):31-9. PubMed ID: 22297037
[TBL] [Abstract][Full Text] [Related]
27. Contrast Induced Nephropathy and Long-term Renal Decline After Percutaneous Transluminal Angioplasty for Symptomatic Peripheral Arterial Disease.
Sigterman TA; Krasznai AG; Snoeijs MG; Heijboer R; Schurink GW; Bouwman LH
Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):386-93. PubMed ID: 26460289
[TBL] [Abstract][Full Text] [Related]
28. Use of NaCl saline hydration and N-Acetyl Cysteine to prevent contrast induced nephropathy in different populations of patients at high and low risk undergoing coronary artery angiography.
Calabrò P; Bianchi R; Caprile M; Sordelli C; Cappelli Bigazzi M; Palmieri R; Gigantino G; Limongelli G; Capozzi G; Cuomo S; Calabrò R
Minerva Cardioangiol; 2010 Feb; 58(1):35-40. PubMed ID: 20145594
[TBL] [Abstract][Full Text] [Related]
29. Preventive effects of anisodamine against contrast-induced nephropathy in type 2 diabetics with renal insufficiency undergoing coronary angiography or angioplasty.
Geng W; Fu XH; Gu XS; Wang YB; Wang XC; Li W; Jiang YF; Hao GZ; Fan WZ; Xue L
Chin Med J (Engl); 2012 Oct; 125(19):3368-72. PubMed ID: 23044290
[TBL] [Abstract][Full Text] [Related]
30. Renal effects of contrast media in diabetic patients undergoing diagnostic or interventional coronary angiography.
Hardiek KJ; Katholi RE; Robbs RS; Katholi CE
J Diabetes Complications; 2008; 22(3):171-7. PubMed ID: 18413220
[TBL] [Abstract][Full Text] [Related]
31. Cardiac Angiography in Renally Impaired Patients (CARE) study: a randomized double-blind trial of contrast-induced nephropathy in patients with chronic kidney disease.
Solomon RJ; Natarajan MK; Doucet S; Sharma SK; Staniloae CS; Katholi RE; Gelormini JL; Labinaz M; Moreyra AE;
Circulation; 2007 Jun; 115(25):3189-96. PubMed ID: 17562951
[TBL] [Abstract][Full Text] [Related]
32. B-type natriuretic peptide for prevention of contrast-induced nephropathy in patients with heart failure undergoing primary percutaneous coronary intervention.
Zhang J; Fu X; Jia X; Fan X; Gu X; Li S; Wu W; Fan W; Su J; Hao G; Jiang Y; Xue L
Acta Radiol; 2010 Jul; 51(6):641-8. PubMed ID: 20438292
[TBL] [Abstract][Full Text] [Related]
33. Can sodium fluorescein cause contrast-induced nephropathy?
Yun D; Kim DK; Lee JP; Kim YS; Oh S; Lim CS
Nephrol Dial Transplant; 2021 Apr; 36(5):819-825. PubMed ID: 31773157
[TBL] [Abstract][Full Text] [Related]
34. The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure.
Kuhn MJ; Chen N; Sahani DV; Reimer D; van Beek EJ; Heiken JP; So GJ
AJR Am J Roentgenol; 2008 Jul; 191(1):151-7. PubMed ID: 18562739
[TBL] [Abstract][Full Text] [Related]
35. Renal impairment and transapical aortic valve implantation: impact of contrast medium dose on kidney function and survival.
Madershahian N; Scherner M; Liakopoulos O; Rahmanian P; Kuhn E; Hellmich M; Mueller-Ehmsen J; Wahlers T
Eur J Cardiothorac Surg; 2012 Jun; 41(6):1225-32. PubMed ID: 22219473
[TBL] [Abstract][Full Text] [Related]
36. Sodium bicarbonate versus normal saline for protection against contrast nephropathy.
Budhiraja P; Chen Z; Popovtzer M
Ren Fail; 2009; 31(2):118-23. PubMed ID: 19212908
[TBL] [Abstract][Full Text] [Related]
37. A prospective, double-blind, randomized, controlled trial on the efficacy and cardiorenal safety of iodixanol vs. iopromide in patients with chronic kidney disease undergoing coronary angiography with or without percutaneous coronary intervention.
Nie B; Cheng WJ; Li YF; Cao Z; Yang Q; Zhao YX; Guo YH; Zhou YJ
Catheter Cardiovasc Interv; 2008 Dec; 72(7):958-65. PubMed ID: 19021282
[TBL] [Abstract][Full Text] [Related]
38. The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: a comparison with periprocedural hemofiltration.
Choi MJ; Yoon JW; Han SJ; Choi HH; Song YR; Kim SG; Oh JE; Lee YK; Seo JW; Kim HJ; Noh JW; Koo JR
Int J Cardiol; 2014 Oct; 176(3):941-5. PubMed ID: 25200848
[TBL] [Abstract][Full Text] [Related]
39. Clinical outcomes of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention: a prospective, multicenter, randomized study to analyze the effect of hydration and acetylcysteine.
Chen SL; Zhang J; Yei F; Zhu Z; Liu Z; Lin S; Chu J; Yan J; Zhang R; Kwan TW
Int J Cardiol; 2008 Jun; 126(3):407-13. PubMed ID: 17651830
[TBL] [Abstract][Full Text] [Related]
40. Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography.
Pesarini G; Lunardi M; Ederle F; Zivelonghi C; Scarsini R; Gambaro A; Lupo A; Vassanelli C; Ribichini F
Am J Cardiol; 2016 Jun; 117(11):1741-6. PubMed ID: 27085934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
